These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5212597)

  • 21. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I; Diumenjo M
    Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
    [No Abstract]   [Full Text] [Related]  

  • 22. Impaired immunoresponsiveness in tumor patients.
    Harris J; Copeland D
    Ann N Y Acad Sci; 1974; 230():56-85. PubMed ID: 4595955
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of antilymphocyte globulin as a study method in the identification of lymphoid antigens expressed by populations of leukemic and/or lymphomatous cells].
    Marmont A
    Minerva Med; 1978 Apr; 69(18):1263-74. PubMed ID: 351459
    [No Abstract]   [Full Text] [Related]  

  • 24. HLA antigens on human peripheral lymphocytes and spleen of malignant lymphoma and other cancer patients.
    Cohen E; Kim U; Blumenson L; Gregory SG; Khurana U; Cox C
    Prog Clin Biol Res; 1977; 16():181-6. PubMed ID: 269456
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum migration-inhibitory activity in patients with lymphoproliferative diseases.
    Cohen S; Fisher B; Yoshida T; Bettigole RE
    N Engl J Med; 1974 Apr; 290(16):882-6. PubMed ID: 4593612
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy.
    Sokal JE
    J Surg Oncol; 1973 Jun; 5(6):557-66. PubMed ID: 4589652
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunoglobulin composition of the blood in hemolymphoblastosis].
    Medina F; Tognella S
    Folia Allergol (Roma); 1967; 14(6):447-52. PubMed ID: 4171226
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune complex disease in the kidneys of lymphoma-leukemia patients: the presence of an oncornavirus-related antigen.
    Sutherland JC; Mardiney MR
    J Natl Cancer Inst; 1973 Mar; 50(3):633-44. PubMed ID: 4267705
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytotoxicity of pathologic human sera for lymphocytes and neutrophils.
    Walford RL; Gallagher R; Taylor P
    Ann N Y Acad Sci; 1965 Jun; 124(2):563-9. PubMed ID: 5214835
    [No Abstract]   [Full Text] [Related]  

  • 30. Scanning the reticuloendothelial system (RES) in hematological diseases.
    Dibos PE; Judisch JM; Spaulding MB; Wagner HN; McIntyre PA
    Johns Hopkins Med J; 1972 Feb; 130(2):68-82. PubMed ID: 4501061
    [No Abstract]   [Full Text] [Related]  

  • 31. Reticuloendothelial system phagocytic function in naturally acquired human malaria.
    Sheagren JN; Tobie JE; Fox LM; Wolff SM
    J Lab Clin Med; 1970 Mar; 75(3):481-7. PubMed ID: 4906744
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunological deficiency in various disorders of lymphoreticular system].
    Frydecka I
    Pol Tyg Lek; 1977 May; 32(22):851-3. PubMed ID: 407553
    [No Abstract]   [Full Text] [Related]  

  • 33. Lymphoid malignancy and development, differentiation, and function of the lymphoreticular system.
    Cooper MD; Peterson RD; Gabrielsen AE; Good RA
    Cancer Res; 1966 Jun; 26(6):1165-9. PubMed ID: 4161635
    [No Abstract]   [Full Text] [Related]  

  • 34. 131 I-labeled colloidal human serum albumin in the study of reticuloendothelial system function. 3. Phagocytosis and catabolism compared in normal, leukemic, and immunosuppressed human subjects.
    Palmer DL; Rifkind D; Brown DW
    J Infect Dis; 1971 May; 123(5):465-9. PubMed ID: 4940078
    [No Abstract]   [Full Text] [Related]  

  • 35. [Quantification of granulocyte protection in hemoblastoses].
    Senn HJ; Jungi WF
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):337-46. PubMed ID: 4139053
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
    Ponzone A; Tarocco RP; Nicola P
    Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on the phagocytic activity of the reticuloendothelial system using 131 I-AA in normal monkeys.
    Areekul S; Kasemsuth R; Chantachum Y; Matrakul D
    Southeast Asian J Trop Med Public Health; 1973 Mar; 4(1):19-26. PubMed ID: 4198004
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F; Lacava V; Fiorilli M; Ciarla MV
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract]   [Full Text] [Related]  

  • 39. I-131-labeled colloidal human serum albumin in the study of reticuloendothelial system function: the distribution of free and colloid-bound radioiodide.
    Palmer DL; Rifkind D; Brown D
    J Lab Clin Med; 1966 Dec; 68(6):972-80. PubMed ID: 5926194
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of reticuloendothelial system phagocytic activity during systemic Candida albicans infection in mice.
    Bird DC; Sheagren JN
    Proc Soc Exp Biol Med; 1970 Jan; 133(1):34-7. PubMed ID: 5412358
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.